Loading...

Curaleaf Holdings, Inc.

CURA.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$5.22
CA$0.44(9.21%)

Curaleaf Holdings, Inc. (CURA.CN) Stock Competitors & Peer Comparison

See (CURA.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$7.89-3.43%2.9B21.92CA$0.36N/A
GTII.CNCA$9.32+13.94%2.3B32.14CA$0.29N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
CURA.TOCA$1.96+3.70%1.5B-4.36-CA$0.45N/A
TRUL.CNCA$6.49+7.81%1.2B-5.95-CA$1.09N/A
CRON.TOCA$2.69-1.82%1B14.16CA$0.19N/A
TLRY.TOCA$0.80+1.27%880.4M-0.24-CA$3.38N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
DHT-UN.TOCA$14.12+1.07%783.7M353.00CA$0.04+3.61%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CURA.CN vs BHC.TO Comparison August 2025

CURA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CURA.CN stands at 4.1B. In comparison, BHC.TO has a market cap of 2.9B. Regarding current trading prices, CURA.CN is priced at CA$5.22, while BHC.TO trades at CA$7.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CURA.CN currently has a P/E ratio of -6.07, whereas BHC.TO's P/E ratio is 21.92. In terms of profitability, CURA.CN's ROE is -0.25%, compared to BHC.TO's ROE of +0.03%. Regarding short-term risk, CURA.CN is more volatile compared to BHC.TO. This indicates potentially higher risk in terms of short-term price fluctuations for CURA.CN.Check BHC.TO's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;